Canaccord Genuity Maintains Buy on Concentrix, Lowers Price Target to $45
Canaccord Genuity analyst Luke Morison maintains Concentrix (NASDAQ: CNXC ) with a Buy and lowers the price target from $55 to $45.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.